(US and Canada) Improzo, a leading innovator in pharma technology, has appointed Jane Urban as Chief Data and Analytics Officer. Urban will report to Chief Technology Officer Abhishek Trigunait and lead enterprise global data strategy, focusing on next-gen analytics, omnichannel engagement, and leveraging GenAI for smarter decision-making.

Urban is a leader in data and analytics in biopharma and technology. She most recently served as Vice President, Customer Engagement Operations at Otsuka Pharmaceutical Companies (U.S.), where she led data digital transformations integrating omnichannel engagement, data science, analytics, and commercial operations to enhance patient and healthcare provider experiences.

Prior to Otsuka, Urban held senior leadership roles at Takeda Pharmaceuticals, including VP, Head of Data, Digital, and Technology for Global Medical and Commercial. She was instrumental in shaping the digital patient journey and driving data-centric decision-making globally Her career also includes impactful roles in analytics, forecasting, marketing, and digital strategy at leading healthcare and consulting organizations.

“Jane’s expertise in data and analytics, along with her proven ability to drive large-scale transformation, will be instrumental as Improzo evolves into a more agile, data-driven organization. Her inspiring leadership will help unlock new opportunities and deliver greater value for our customers and communities,” said Inderpreet Kambo, CEO of Improzo.

Urban was recognized by CDO Magazine as a Top 40 Under 40 Data Leader two years in a row and a Global Data Power Woman in 2024. She holds a position on the CDO Magazine Global Editorial Board, showcasing her contributions to the field of data.

She holds a bachelor’s degree in engineering from Brown University and an MBA from the Kellogg School of Management at Northwestern University and is known for her leadership and passion for technology-driven impact.